BioTech Startup Akribion Raises €8m for Programmable Cell Depletion
Akribion Therapeautics, a Zwingenberg-based BioTech startup developing a RNA-guided, nuclease-based technology for programmable cell depletion, recently announced its exit from stealth and the completion of a Seed financing round raising…
Read More